Last $51.31 USD
Change Today -0.05 / -0.10%
Volume 122.3K
ABCO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 1:37 PM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

advisory board co/the (ABCO) Snapshot

Open
$51.40
Previous Close
$51.36
Day High
$51.61
Day Low
$50.75
52 Week High
10/30/13 - $70.55
52 Week Low
05/9/14 - $46.58
Market Cap
1.9B
Average Volume 10 Days
201.3K
EPS TTM
$0.60
Shares Outstanding
36.3M
EX-Date
--
P/E TM
85.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for ADVISORY BOARD CO/THE (ABCO)

advisory board co/the (ABCO) Related Businessweek News

No Related Businessweek News Found

advisory board co/the (ABCO) Details

The Advisory Board Company provides best practices research and analysis, business intelligence and performance technology software, and consulting and management services to the health care and education industries in the United States and internationally. Its best practices research and insight programs include access to studies, executive education, proprietary databases and online services, executive briefings, and other services. The company’s best practices research and insight memberships serve as the foundation of intellectual property across various programs and are focused on understanding industry dynamics, identifying best-demonstrated management practices, critiquing widely-followed but ineffective practices, and analyzing emerging trends within the health care and education industries. Its performance technologies software tools allow members to increase revenue, reduce cost, and enhance quality by pairing their own operational data with the best practices insights from its research; and consulting and management services provides strategic and operational support to member institutions to achieve key clinical quality and financial performance goals, as well as assist member institutions’ efforts to adopt and implement best practices. The company offers its services through discrete programs to approximately 4,500 organizations, including hospitals, health systems, pharmaceutical and biotechnology companies, health care insurers, medical device companies, colleges, universities, and other health care focused organizations and educational institutions. The Advisory Board Company was founded in 1979 and is headquartered in Washington, District of Columbia.

2,800 Employees
Last Reported Date: 05/30/14
Founded in 1979

advisory board co/the (ABCO) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $641.7K
President and Director
Total Annual Compensation: $470.8K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $325.0K
President of Performance Technologies and Con...
Total Annual Compensation: $425.0K
Executive Vice President
Total Annual Compensation: $350.0K
Compensation as of Fiscal Year 2014.

advisory board co/the (ABCO) Key Developments

The Advisory Board Company Presents at William Blair & Company's 34th Annual Growth Stock Conference, Jun-10-2014 12:50 PM

The Advisory Board Company Presents at William Blair & Company's 34th Annual Growth Stock Conference, Jun-10-2014 12:50 PM. Venue: Four Seasons Hotel, 120 East Delaware Place, Chicago, Illinois, United States. Speakers: Michael T. Kirshbaum, Chief Financial Officer, Principal Accounting Officer and Treasurer, Robert W. Musslewhite, Chairman and Chief Executive Officer.

The Advisory Board Company Announces Unaudited Consolidated for the Fourth Quarter and Year Ended March 31, 2014; Reaffirms Earnings Guidance for 2014

The Advisory Board Company announced unaudited consolidated for the fourth quarter and year ended March 31, 2014. Revenue for the quarter increased 15% to $138.0 million, from $119.7 million for the quarter ended March 31, 2013. For the quarter ended March 31, 2014, net income attributable to common stockholders was $8.3 million, or $0.22 per diluted share, compared to net income attributable to common stockholders of $6.5 million, or $0.18 per diluted share, for the quarter ended March 31, 2013. For the quarter ended March 31, 2014, adjusted EBITDA was $26.0 million, up from $23.1 million for the quarter ended March 31, 2013. Adjusted net income for the quarter ended March 31, 2014 was $12.6 million, or $0.34 per diluted share, compared to $12.3 million, or $0.34 per diluted share, for the quarter ended March 31, 2013. Operating income was $17.183 million against $12.884 million a year ago. Income before provision for income taxes and equity in loss of unconsolidated entities was $17.915 million against $13.486 million a year ago. Cash flow during the three months ended March 31, 2014, or cash flow provided by operating activities was $3.1 million compared to $9.3 million in the same quarter last year. For the fiscal year ended March 31, 2014, revenue increased 16% to $520.6. million, from $450.8 million for the fiscal year ended March 31, 2013. Net income attributable to common stockholders was $24.8 million, or $0.67 per diluted share, for the fiscal year ended March 31, 2014, compared to net income attributable to common stockholders of $23.4 million, or $0.64 per diluted share, for the prior fiscal year. For the fiscal year ended March 31, 2014, adjusted EBITDA was $92.2 million, up from $84.4 million for the fiscal year ended March 31, 2013. Adjusted net income for the fiscal year ended March 31, 2014 was $44.9 million, or $1.22 per diluted share, compared to $45.4 million, or $1.25 per diluted share, for the fiscal year ended March 31, 2013. Operating income was $47,186 million against $45.475 million a year ago. Income before provision for income taxes and equity in loss of unconsolidated entities was $49.892 million against $48.079 million a year ago. Net cash flows provided by operating activities was $76.702 million against $83.261 million a year ago. Purchases of property and equipment was $44.058 million against $36.979 million a year ago. Capitalized external use software development costs was $5.071 million against $3.393 million a year ago. The company is reaffirming its revenue guidance range of approximately $570 million to $580 million for calendar year 2014. The company is revising its guidance for adjusted EBITDA to be in a range of approximately $97 million to $103 million, and non-GAAP earnings per diluted share to be in a range of approximately $1.14 to $1.25, based on projected dilution and integration expenses from an acquisition that closed on May 5th. For calendar year 2014, the company expects amortization from acquisition-related intangible assets to be approximately $11 million and effective tax rate in a range of approximately 38.5% to 39.5%. For fiscal 2014, cash flow generated from operations was 1.7x adjusted net income consistent with the typical range of 1.5 to 2x. Capital expenditures for the year ended March 31, 2014, were approximately $49.1 million compared to $40.4 million last year.

The Advisory Board Company to Report Q4, 2014 Results on May 08, 2014

The Advisory Board Company announced that they will report Q4, 2014 results After-Market on May 08, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABCO:US $51.31 USD -0.05

ABCO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Corporate Executive Board Co/The $64.73 USD +1.22
Grand Canyon Education Inc $44.64 USD +0.13
Huron Consulting Group Inc $63.30 USD -2.61
Korn/Ferry International $30.16 USD +0.19
MedAssets Inc $25.30 USD +0.73
View Industry Companies
 

Industry Analysis

ABCO

Industry Average

Valuation ABCO Industry Range
Price/Earnings 76.7x
Price/Sales 3.6x
Price/Book 5.5x
Price/Cash Flow 33.8x
TEV/Sales 3.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADVISORY BOARD CO/THE, please visit www.advisory.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.